Ligands to the integrin receptor αvβ3

Expert Opinion on Therapeutic Patents

Volumn 12, Issue 7, 2002, Pages 1009-1021

  Coleman, Paul J ^a   Duong, Le T ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

v 3 integrin; Angiogenesis; Arthritis; Bone resorption; Osteoclast; Osteoporosis; Vitronectin receptor

Indexed keywords

2 PYRROLIDONE DERIVATIVE; ARGININE; ASPARTIC ACID; BENZAZEPINE DERIVATIVE; CARBAMIC ACID DERIVATIVE; CYCLOHEPTANE DERIVATIVE; EMD 12174; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCINE; HEPTANE; HYDRAZINE DERIVATIVE; INTEGRIN RECEPTOR; LIGAND; MONOCLONAL ANTIBODY LM 609; OXAZEPINE DERIVATIVE; PENTAPEPTIDE; PYRIMIDINE DERIVATIVE; PYRIMIDINONE DERIVATIVE; PYRROLIDINE DERIVATIVE; RECEPTOR BLOCKING AGENT; RECEPTOR SUBUNIT; SB 235123; SCLEROPROTEIN; SKB 273005; ST 1646; SULFONAMIDE; THIOPHENE DERIVATIVE; TRIPEPTIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITRONECTIN RECEPTOR;

ANGIOGENESIS; CANCER; CELL INTERACTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; DOSE RESPONSE; DRUG ACTIVITY; DRUG CLEARANCE; DRUG EFFICACY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; EXTRACELLULAR MATRIX; HUMAN; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; PATENT; PROTEIN EXPRESSION; PROTEIN FAMILY; REVIEW; RHEUMATOID ARTHRITIS; SIDE EFFECT;

EID: 0036313063     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.12.7.1009     Document Type: Review

References (31)

1. Integrin signaling
2. Function and interactions of integrins
3. The role of integrins in osteoclast function
4. Integrin antagonists as inhibitors of bone resorption: Implications for treatment
5. Integrin structure
6. 3 in complex with an Arg-Gly-Asp ligand
7. Electron microscopy and structural model of human fibronectin receptor
8. Ligand binding to integrins
9. Integrin function in osteoclasts
10. 3 integrins are osteosclerotic because of dysfunctional osteoclasts
11. Echistatin inhibits the migration of murine prefusion osteoclasts and the formation of multinucleated osteoclast-like cells
12. Adhesion events in angiogenesis
13. 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo
14. v integrins during angiogenesis
15. 3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy
16. Small molecule α(v) integrin antagonists: Novel anticancer agents
17. Vitaxin applied molecular evolution
18. v integrins
19. 5-deficient mice
20. 5 integrins
21. Targeting of vasculature in cancer and other angiogenic diseases
22. A role for angiogenesis in rheumatoid arthritis
23. 3 antagonist
24. 3 (the vitronectin receptor)
25. Cilengitide
26. 5 integrin inhibitor that perturbs tumor angiogenesis, in patients with solid tumors
27. 3 antagonists. Part 3: Identification of potent RGD mimetics incorporating novel β-amino acids as aspartic acid replacements
28. Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimetic
29. Design and characterization of an orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist, SB 265123, for the prevention of bone loss in osteoporosis
30. 3 receptor antagonists
31. 3 antagonists. Part 4. Potent and orally bioavailable chain-shortened RGD mimetics